REQUEST A DEMO
Total
USD $0.00
Search more companies

HARSFA PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: HARSFA PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

HARSFA PHARMA Kft. is an enterprise based in Hungary. Its main office is in Jakabszallas. The enterprise currently operates in the Pharmacies and Drug Stores sector. HARSFA PHARMA Kft. was incorporated on June 12, 2013. 3 (2024) employees currently work for HARSFA PHARMA Kft.. In 2023, the company reported a net sales revenue increase of 13.69%. Its total assets grew by 4.82% over the same period. In 2023, HARSFA PHARMA Kft.’s net profit margin increased by 1.19%.

Headquarters
Petofi Sandor utca 6. B. ep.
Jakabszallas; Bacs-Kiskun; Postal Code: 6078

Contact Details: Purchase the HARSFA PHARMA Kft. report to view the information.

Website: http://www.tilia.hu

Basic Information
Total Employees:
Purchase the HARSFA PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the HARSFA PHARMA Kft. report to view the information.
Registered Capital:
Purchase the HARSFA PHARMA Kft. report to view the information.
Incorporation Date:
June 12, 2013
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after HARSFA PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.69%
Total operating revenue
13.53%
Operating profit (EBIT)
23.86%
EBITDA
20.17%
Net Profit (Loss) for the Period
24.96%
Total assets
4.82%
Total equity
17.24%
Operating Profit Margin (ROS)
1.2%
Net Profit Margin
1.19%
Return on Equity (ROE)
3.56%
Quick Ratio
1.39%
Cash Ratio
1.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?